In practice, many obesity specialists have found themselves deviating from the label slowing down titration, adding intermediate doses, maintaining lower doses longer, or skipping weeks to help patients stay on therapy
The guide on GLP-1 use while breastfeeding covers the available evidence and considerations for this population
Healthcare providers typically start with lower doses and gradually increase them to help your body adjust while minimizing any discomfort
Peters V, Tigchelaar-Feenstra EF, Imhann F, Dekens JAM, Swertz MA, Franke LH, et al
Qualitative studies of trial participants reveal early-onset appetite changes, with 86% of treated participants reporting alterations in eating behaviors within the first 8 weeks of treatment
Im not sure how they came to that conclusion, but it felt very promising